血漿市場：製品別、用途別、治療適応症別、エンドユーザー別、地域別

世界の血漿市場は、2025年には3,880万米ドルと推定され、2032年には7,950万米ドルに達すると予測され、2025年から2032年までの年間平均成長率（CAGR）は10.8%で成長する見込みです。

世界の血漿市場は、様々な慢性疾患や生命を脅かす疾患の治療において重要な役割を果たし、ヘルスケア産業の重要な構成要素として台頭してきました。血液の液体部分である血漿には、治療製品の開発に使用される必須タンパク質、凝固因子、抗体が含まれています。同市場の重要性は、免疫不全、血友病、神経疾患などの治療に使用される血漿由来の治療薬に対する需要の高まりに対応する能力にあります。これらの疾患の有病率が上昇を続ける中、血漿の収集・分画技術の進歩も相まって、世界の血漿市場は大幅な成長を遂げようとしています。

市場力学：

世界の血漿市場は、慢性疾患の有病率の増加、老人人口の増加、免疫グロブリンの需要増など、いくつかの要因によって牽引されています。原発性免疫不全症や神経疾患など、さまざまな病態の治療における血漿由来療法の用途拡大が、市場の成長をさらに後押ししています。さらに、血漿の採取と分画技術の進歩により、血漿由来製品の効率性と安全性が向上し、市場の成長を後押ししています。しかし市場には、血漿由来の治療薬が高価であることや、血液を介して感染症に感染するリスクがあることなど、一定の抑制要因もあります。さらに、血漿製品の収集、加工、流通を管理する厳しい規制は、市場参入企業に課題をもたらす可能性があります。このような市場抑制要因はあるもの、新興経済諸国における血漿由来療法の需要増加、新規血漿由来製品の市場開拓、組換え血漿タンパク質の採用増加などにより、市場には大きな成長機会がもたらされています。さらに、血漿提供の利点に関する意識の高まりと、世界の血漿収集センターの拡大が、今後数年間の市場成長に寄与すると予想されます。

本調査の主な特徴

• 本レポートでは、世界の血漿市場を詳細に分析し、2024年を基準年とした予測期間（2025-2032年）の市場規模（USD Mn）および複合年間成長率（CAGR%）を掲載しています。
• また、さまざまなセグメントにわたる潜在的な収益機会を明らかにし、この市場の魅力的な投資提案のマトリックスについて説明しています。
• また、市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域別の展望、主要企業が採用する競争戦略などに関する重要な考察も提供しています。
• 企業ハイライト、製品ポートフォリオ、主要なハイライト、財務実績、戦略などのパラメータに基づいて、世界の血漿市場の主要企業をプロファイルしています。
• このレポートからの洞察は、マーケティング担当者や企業の経営陣が、将来の製品の発売、タイプのアップグレード、市場拡大、マーケティング戦術に関する情報に基づいた意思決定を行うことを可能にします。
• 世界の血漿市場レポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この業界の様々な利害関係者に対応しています。
• 利害関係者は、世界の血漿市場の分析に使用される様々な戦略マトリックスを通じて、意思決定が容易になります。

目次

第1章 調査の目的と前提条件

• 調査目的
• 前提条件
• 略語

第2章 市場の展望

• レポートの説明
  • 市場の定義と範囲
• エグゼクティブサマリー

第3章 市場力学、規制、動向分析

• 市場力学
• 影響分析
• 主な発展
• 規制シナリオ
• 製品の発売/承認
• PEST分析
• PORTERの分析
• 合併と買収のシナリオ
• 業界動向

第4章 世界の血漿市場、製品別、2020年～2032年

• 免疫グロブリン
• アルブミン
• 凝固因子濃縮物
• 第VIII因子
• 第IX因子
• フォン・ヴィレブランド因子
• プロトロンビン複合体濃縮物
• フィブリノゲン濃縮物
• 第XIII因子
• アルファ1アンチトリプシン
• その他

第5章 世界の血漿市場、用途別、2020年～2032年

• セグメントの動向
• 免疫不全疾患
• 血友病
• フォン・ヴィレブランド病
• その他

第6章 世界の血漿市場、治療適応症別、2020年～2032年

• 免疫学
• 腫瘍学
• 呼吸器科
• リウマチ学
• 移植
• 神経学
• 血液学
• その他

第7章 世界の血漿市場、供給源別、2020年～2032年

• 原料血漿
• 回収血漿

第8章 世界の血漿市場、エンドユーザー別、2020年～2032年

• 病院と診療所
• 研究ラボ
• 血漿採取センター
• 学術病院機関
• バイオ医薬品企業
• その他

第9章 世界の血漿市場、地域別、2020年～2032年、価値

• 北米
  • 米国
  • カナダ
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
  • メキシコ
  • その他ラテンアメリカ
• 欧州
  • ドイツ
  • 英国
  • スペイン
  • フランス
  • イタリア
  • ロシア
  • その他欧州
• アジア太平洋
  • 中国
  • インド
  • 日本
  • オーストラリア
  • 韓国
  • ASEAN
  • その他アジア太平洋地域
• 中東
  • GCC諸国
  • イスラエル
  • その他中東
• アフリカ
  • 南アフリカ
  • 北アフリカ
  • 中央アフリカ

第10章 競合情勢

• CSL Behring
• Grifols
• Takeda Pharmaceutical Company Limited（formerly Shire）
• Octapharma
• Kedrion Biopharma
• Bio Products Laboratory（BPL）
• LFB Group
• Sanquin Plasma Products
• China Biologic Products Holdings, Inc
• ADMA Biologics
• GC Pharma
• CSL Plasma
• Emergent BioSolutions
• Kamada
• Centurion Pharma

第11章 アナリストの推奨事項

• 機会
• アナリストの見解
• Coherent Opportunity Map

第12章 参考文献と調査手法

• 参考文献
• 調査手法
• 出版社について

Global Blood Plasma Market is estimated to be valued at USD 38.8 Mn in 2025 and is expected to reach USD 79.5 Mn by 2032, growing at a compound annual growth rate (CAGR) of 10.8% from 2025 to 2032.

The global blood plasma market has emerged as a vital component of the healthcare industry, playing a crucial role in the treatment of various chronic and life-threatening diseases. Blood plasma, the liquid portion of blood, contains essential proteins, clotting factors, and antibodies that are used in the development of therapeutic products. The market's significance lies in its ability to address the growing demand for plasma-derived therapies, which are used to treat conditions such as immune deficiencies, hemophilia, and neurological disorders. As the prevalence of these diseases continues to rise, coupled with advancements in plasma collection and fractionation technologies, the global blood plasma market is poised for substantial growth.

Market Dynamics:

The global blood plasma market is driven by several factors, including the increasing prevalence of chronic diseases, the growing geriatric population, and the rising demand for immunoglobulins. The expanding applications of plasma-derived therapies in the treatment of various medical conditions, such as primary immunodeficiency disorders and neurological diseases, further fuel the market's growth. Additionally, advancements in plasma collection and fractionation technologies have improved the efficiency and safety of plasma-derived products, thereby boosting market growth. However, the market also faces certain restraints, such as the high cost of plasma-derived therapies and the risk of transmission of blood-borne infections. Moreover, stringent regulations governing the collection, processing, and distribution of blood plasma products can pose challenges to market participants. Despite these restraints, the market presents significant opportunities for growth, driven by the increasing demand for plasma-derived therapies in emerging economies, the development of novel plasma-derived products, and the rising adoption of recombinant plasma proteins. Furthermore, the growing awareness about the benefits of plasma donation and the expansion of plasma collection centers worldwide are expected to contribute to the market's growth in the coming years.

Key Features of the Study:

• This report provides in-depth analysis of the global blood plasma market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global blood plasma market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include CSL Behring, Grifols, Takeda Pharmaceutical Company Limited, Octapharma, Kedrion Biopharma, Bio Products Laboratory (BPL), LFB Group, Sanquin Plasma Products, China Biologic Products Holdings, Inc, ADMA Biologics, GC Pharma, CSL Plasma, Emergent BioSolutions, Kamada, and Centurion Pharma
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global blood plasma market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global blood plasma market

Market Segmentation

• Product Insights (Revenue, USD Mn, 2020 - 2032)
  • Immunoglobulins
  • Albumin
  • Coagulation Factor Concentrates
  • Factor VIII
  • Factor IX
  • Von Willebrand Factor
  • Prothrombin Complex Concentrate
  • Fibrinogen Concentrates
  • Factor XIII
  • Alpha-1 Antitrypsin
  • Others
• Application Insights (Revenue, USD Mn, 2020 - 2032)
  • Hypogammaglobulinemia
  • Immunodeficiency Diseases
  • Hemophilia
  • Von Willebrand's Disease
  • Others
• Therapeutic Indication Insights (Revenue, USD Mn, 2020 - 2032)
  • Immunology
  • Oncology
  • Pulmonology
  • Rheumatology
  • Transplantation
  • Neurology
  • Hematology
  • Others
• Source Insights (Revenue, USD Mn, 2020 - 2032)
  • Source Plasma
  • Recovered Plasma
• End User Insights (Revenue, USD Mn, 2020 - 2032)
  • Hospitals & Clinics
  • Research Laboratories
  • Plasma Collection Centers
  • Academic & Research Institutes
  • Biopharmaceutical Companies
  • Others
• Regional Insights (Revenue, USD Mn, 2020 - 2032)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
  • CSL Behring
  • Grifols
  • Takeda Pharmaceutical Company Limited (formerly Shire)
  • Octapharma
  • Kedrion Biopharma
  • Bio Products Laboratory (BPL)
  • LFB Group
  • Sanquin Plasma Products
  • China Biologic Products Holdings, Inc
  • ADMA Biologics
  • GC Pharma
  • CSL Plasma
  • Emergent BioSolutions
  • Kamada
  • Centurion Pharma

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Blood Plasma Market, By Product
  • Global Blood Plasma Market, By Application
  • Global Blood Plasma Market, By Therapeutic Indication
  • Global Blood Plasma Market, By Source
  • Global Blood Plasma Market, By End User
  • Global Blood Plasma Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Driver
  • Restraint
  • Opportunity
• Impact Analysis
• Key Developments
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario
• Industry Trends

4. Global Blood Plasma Market, By Product, 2020-2032, (USD Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Immunoglobulins
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Albumin
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Coagulation Factor Concentrates
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Factor VIII
• Factor IX
• Von Willebrand Factor
• Prothrombin Complex Concentrate
• Fibrinogen Concentrates
• Factor XIII
• Alpha-1 Antitrypsin
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

5. Global Blood Plasma Market, By Application, 2020-2032, (USD Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
• Segment Trends
  • Hypogammaglobulinemia
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Immunodeficiency Diseases
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Hemophilia
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Von Willebrand's Disease
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

6. Global Blood Plasma Market, By Therapeutic Indication, 2020-2032, (USD Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Immunology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Oncology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Pulmonology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Rheumatology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Transplantation
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Neurology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Hematology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

7. Global Blood Plasma Market, By Source, 2020-2032, (USD Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Source Plasma
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Recovered Plasma
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

8. Global Blood Plasma Market, By End User, 2020-2032, (USD Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Hospitals & Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Research Laboratories
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Plasma Collection Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Academic & Research Institutes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Biopharmaceutical Companies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

9. Global Blood Plasma Market, By Region, 2020 - 2032, Value (USD Mn)

• Introduction
  • Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Mn)
  • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Mn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Product, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Therapeutic Indication, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Source, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Product, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Therapeutic Indication, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Source, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Product, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Therapeutic Indication, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Source, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Product, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Therapeutic Indication, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Source, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Product, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Therapeutic Indication, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Source, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Product, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Therapeutic Indication, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Source, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Mn)
    • South Africa
    • North Africa
    • Central Africa

10. Competitive Landscape

• CSL Behring
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Grifols
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Takeda Pharmaceutical Company Limited (formerly Shire)
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Octapharma
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Kedrion Biopharma
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Bio Products Laboratory (BPL)
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• LFB Group
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Sanquin Plasma Products
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• China Biologic Products Holdings, Inc
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• ADMA Biologics
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• GC Pharma
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• CSL Plasma
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Emergent BioSolutions
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Kamada
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Centurion Pharma
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies

11. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

12. References and Research Methodology

• References
• Research Methodology
• About us